{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:39:38Z","timestamp":1782556778951,"version":"3.54.5"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Noninvasive prenatal testing (NIPT) using cell-free DNA (cfDNA) is typically carried out to screen for common fetal chromosomal anomalies, with the option to screen for a wider range of chromosomal changes (expanded NIPT) becoming increasingly available. However, little is known about pregnant patients\u2019 attitudes and preferences regarding expanded NIPT.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> To address this gap, we surveyed general-risk patients having first-tier cfDNA screening at a private prenatal clinic on their expectations for expanded NIPT. Patients were asked questions regarding their current pregnancy and previous pregnancy history, their opinions on fetal DNA screenings during pregnancy and incidental findings, information and opinions on financial resources for NIPT, as well as socio-cultural questions to determine patient demographics.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 200 survey participants, the majority were educated, self-reported as white, had a higher than average income, and reported no aneuploidy risk factors. When asked what information they would like to receive from cfDNA screening, the vast majority of participants wanted all information available that could have an immediate impact on fetal health (88%) or an immediate impact on infant health from birth (82%). Many participants also wanted information that could have a future impact on the child\u2019s health or an immediate or future impact on the pregnant woman\u2019s own health. Most participants wanted information about the sex of fetus (86%) and common trisomies (71%), with almost half of participants desiring information about rare autosomal aneuploidies and\/or all genetic information that may affect the baby. In addition, participants were found to be comfortable screening for conditions that are well-known, influence care during pregnancy, and are treatable. Finally, while most respondents either had insurance coverage for NIPT or were able to afford NIPT out of pocket, the majority of our participants felt that expanded NIPT should be either free for everyone or for those considered high risk.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Our findings suggest that with appropriate pre-test counseling, pregnant patients may choose NIPT for an expanding list of conditions.<\/jats:p>","DOI":"10.3389\/fgene.2023.976051","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:19:38Z","timestamp":1681795178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Patient attitudes and preferences about expanded noninvasive prenatal testing"],"prefix":"10.3389","volume":"14","author":[{"given":"Marie-Line","family":"Dubois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia D.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Rodrigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2516865718813122","DOI":"10.1177\/2516865718813122","article-title":"Knowledge, attitudes, and practices of women toward prenatal genetic testing","volume":"11","author":"Abdo","year":"2018","journal-title":"Epigenet Insights"},{"key":"B2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/pd.4594","article-title":"A first look at women's perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes","volume":"35","author":"Agatisa","year":"2015","journal-title":"Prenat. Diagn"},{"key":"B3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/aog.0000000000004107","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin summary, number 226","volume":"136","year":"2020","journal-title":"Obstetrics Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jogc.2017.01.032","article-title":"No. 348-Joint SOGC-CCMG guideline: Update on prenatal screening for fetal aneuploidy, fetal anomalies, and adverse pregnancy outcomes","volume":"39","author":"Audibert","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/aog.0000000000004809","article-title":"Evaluating expanded noninvasive prenatal screening","volume":"139","author":"Bayefsky","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"103616","DOI":"10.1016\/j.ejmg.2019.01.006","article-title":"Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers","volume":"63","author":"Benachi","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/pd.4608","article-title":"Position statement from the chromosome abnormality screening committee on behalf of the board of the international society for prenatal diagnosis","volume":"35","author":"Benn","year":"2015","journal-title":"Prenat. Diagn"},{"key":"B8","volume-title":"NIPT good clinical practice guidelines","year":"2017"},{"key":"B9","volume-title":"Belgian guidelines for managing incidental findings detected by NIP","year":"2020"},{"key":"B10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1515\/jpm-2021-0290","article-title":"The implementation of non-invasive prenatal testing (NIPT) in The Netherlands","volume":"49","author":"Bilardo","year":"2021","journal-title":"J. Perinat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12884-018-2153-y","article-title":"The value of non-invasive prenatal testing: Preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access","volume":"19","author":"Birko","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"B12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/medethics-2018-105167","article-title":"'Is it better not to know certain things?': Views of women who have undergone non-invasive prenatal testing on its possible future applications","volume":"45","author":"Bowman-Smart","year":"","journal-title":"J. Med. Ethics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/ajo.12945","article-title":"Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing","volume":"59","author":"Bowman-Smart","year":"","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/pd.4760","article-title":"Patient preferences for prenatal testing of microdeletion and microduplication syndromes","volume":"36","author":"Calonico","year":"2016","journal-title":"Prenat. Diagn"},{"key":"B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12884-018-2168-4","article-title":"Facilitating informed choice about non-invasive prenatal testing (NIPT): A systematic review and qualitative meta-synthesis of women's experiences","volume":"19","author":"Cernat","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1016\/j.jogc.2017.06.013","article-title":"No. 261-Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"39","author":"Chitayat","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"B17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/ajo.13436","article-title":"Experiences of non-invasive prenatal screening: A survey study","volume":"62","author":"Cornell","year":"2022","journal-title":"Aust. N. Z. J. Obstetrics Gynaecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","article-title":"Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening","volume":"23","author":"Dondorp","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.gim.2022.11.004","article-title":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Dungan","year":"2022","journal-title":"Genet. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/humupd\/dmab009","article-title":"Confined placental mosaicism and the association with pregnancy outcome and fetal growth: A review of the literature","volume":"27","author":"Eggenhuizen","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"B21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/birt.12113","article-title":"What women want: Lead considerations for current and future applications of noninvasive prenatal testing in prenatal care","volume":"41","author":"Farrell","year":"","journal-title":"Birth"},{"key":"B22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/jcm3020614","article-title":"It\u2019s more than a blood test: Patients\u2019 perspectives on noninvasive prenatal testing","volume":"3","author":"Farrell","year":"","journal-title":"J. Clin. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jemep.2016.05.002","article-title":"Expanded indications for noninvasive prenatal genetic testing: Implications for the individual and the public","volume":"2","author":"Farrell","year":"2016","journal-title":"Ethics, Med. Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12910-020-0455-x","article-title":"Implementation challenges for an ethical introduction of noninvasive prenatal testing: A qualitative study of healthcare professionals' views from Lebanon and Quebec","volume":"21","author":"Haidar","year":"2020","journal-title":"BMC Med. Ethics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12884-020-03538-y","article-title":"A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing","volume":"21","author":"Haidar","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"B26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/jcm11020372","article-title":"Initial clinical experience with NIPT for rare autosomal aneuploidies and large copy number variations","volume":"11","author":"Harasim","year":"2022","journal-title":"J. Clin. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/medethics-2017-104729","article-title":"Ethics of routine: A critical analysis of the concept of 'routinisation' in prenatal screening","volume":"44","author":"Kater-Kuipers","year":"2018","journal-title":"J. Med. Ethics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/pd.2205","article-title":"The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA","volume":"29","author":"Kooij","year":"2009","journal-title":"Prenat. Diagn"},{"key":"B29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1055\/a-0631-8898","article-title":"DEGUM, \u00f6gum, SGUM and FMF Germany recommendations for the implementation of first-trimester screening, detailed ultrasound, cell-free DNA screening and diagnostic procedures","volume":"40","author":"Kozlowski","year":"2019","journal-title":"Ultraschall Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/1471-0528.12579","article-title":"Non-invasive prenatal testing for trisomy 21: A cross-sectional survey of service users' views and likely uptake","volume":"121","author":"Lewis","year":"2014","journal-title":"BJOG"},{"key":"B31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/pd.4879","article-title":"A qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy","volume":"36","author":"Lewis","year":"","journal-title":"Prenat. Diagn"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0153147","DOI":"10.1371\/journal.pone.0153147","article-title":"Women's experiences and preferences for service delivery of non-invasive prenatal testing for aneuploidy in a public health setting: A mixed methods study","volume":"11","author":"Lewis","year":"","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"975987","DOI":"10.3389\/fgene.2022.975987","article-title":"Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes","volume":"13","author":"Mossfield","year":"2022","journal-title":"Front. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/clinchem\/hvab067","article-title":"Performance of a paired-end sequencing-based noninvasive prenatal screening test in the detection of genome-wide fetal chromosomal anomalies","volume":"67","author":"Pertile","year":"2021","journal-title":"Clin. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/gim.2016.72","article-title":"Cell-free DNA testing of an extended range of chromosomal anomalies: Clinical experience with 6,388 consecutive cases","volume":"19","author":"Pescia","year":"2017","journal-title":"Genet. Med."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2020-0043","article-title":"Prenatal screening and diagnosis of genetic abnormalities: SEGO, SEQCML, AEDP consensus recommendations","volume":"1","author":"Prieto","year":"2020","journal-title":"Adv. Laboratory Med.\/Avances en Med. de Laboratorio"},{"key":"B37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-genom-083118-015053","article-title":"The emergence and global spread of noninvasive prenatal testing","volume":"22","author":"Ravitsky","year":"2021","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/aog.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226","volume":"136","author":"Rose","year":"2020","journal-title":"Obstetrics Gynecol."},{"key":"B39","volume-title":"Non-invasive prenatal testing for chromosomal abnormality using maternal plasma","year":"2014"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0156088","DOI":"10.1371\/journal.pone.0156088","article-title":"Positive attitudes towards non-invasive prenatal testing (NIPT) in a Swedish cohort of 1,003 pregnant women","volume":"11","author":"Sahlin","year":"2016","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/uog.17483","article-title":"ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice","volume":"49","author":"Salomon","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41436-021-01135-8","article-title":"Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants","volume":"23","author":"Soster","year":"2021","journal-title":"Genet. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/aog.0000000000003121","article-title":"Noninvasive prenatal whole genome sequencing: Pregnant women's views and preferences","volume":"133","author":"Sullivan","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/pd.4495","article-title":"Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting","volume":"35","author":"Tiller","year":"2015","journal-title":"Prenat. Diagn"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1200\/jco.22.00733","article-title":"Prenatal DNA sequencing for fetal aneuploidy also detects maternal cancer: Importance of timely workup and management in pregnant women","volume":"40","author":"Turriff","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-022-01248-x","article-title":"Experiences of pregnant women with genome-wide non-invasive prenatal testing in a national screening program","author":"van der Meij","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","article-title":"Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study","volume":"109","author":"van Prooyen Schuurman","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ejhg.2014.32","article-title":"Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening","volume":"22","author":"van Schendel","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/pd.4579","article-title":"NIPT-Based screening for down syndrome and beyond: What do pregnant women think?","volume":"35","author":"van Schendel","year":"2015","journal-title":"Prenat. Diagn"},{"key":"B50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ejhg.2011.246","article-title":"Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe","volume":"20","author":"Wellesley","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"B51","volume-title":"Cell free DNA testing for aneuploidies: A fact sheet for healthcare providers","author":"Wou","year":"2021"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.976051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:35:21Z","timestamp":1684413321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.976051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":51,"alternative-id":["10.3389\/fgene.2023.976051"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.976051","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"article-number":"976051"}}